Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030. The market is driven by factors such as increasing incidence of cancer, rising awareness about CINV drugs, and technological advancements in the field of oncology.
The global chemotherapy induced nausea and vomiting (CINV) drugs market is segmented on the basis of type into aloxi, zofran generic, kytril generic, emend, akynzeo, sustol and rolapitant; application into acute CINV and delayed CINV; region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
-The global CINV drugs market is expected to grow at a CAGR of 4.5% from 2017 to 2022.
-The US is the largest market for CINV drugs, accounting for over 50% of the total revenue in 2016.
-CINV drugs are available as oral tablets, capsules, or liquids that can be taken with or without food.
Industry Growth Insights published a new data on “Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market”. The research report is titled “Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market research by Types (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant), By Applications (Acute CINV, Delayed CINV), By Players/Companies GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck, Tesaro”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Research Report
By Type
Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant
By Application
Acute CINV, Delayed CINV
By Companies
GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck, Tesaro
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
 Drugs Industry Outlook.svg)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report Segments:
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is segmented on the basis of:
Types
Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL, Rolapitant
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute CINV, Delayed CINV
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Helsinn
- Heron Therapeutics
- Merck
- Tesaro
 Drugs Market Overview.svg)
Highlights of The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aloxi
- Zofran Generic
- Kytril Generic
- Emend
- Akynzeo
- SUSTOL
- Rolapitant
- By Application:
- Acute CINV
- Delayed CINV
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Drugs Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chemotherapy induced nausea and vomiting (CINV) drugs are medications that can help to prevent or reduce the symptoms of chemotherapy-induced nausea and vomiting. CINV drugs may be prescribed by a doctor in combination with other treatments for cancer, such as radiation therapy or surgery.
Some of the key players operating in the chemotherapy induced nausea and vomiting (cinv) drugs market are GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck, Tesaro.
The chemotherapy induced nausea and vomiting (cinv) drugs market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market - Supply Chain
4.5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Forecast
4.5.1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Absolute $ Opportunity
5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
5.3.1. Aloxi
5.3.2. Zofran Generic
5.3.3. Kytril Generic
5.3.4. Emend
5.3.5. Akynzeo
5.3.6. SUSTOL
5.3.7. Rolapitant
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
6.3.1. Acute CINV
6.3.2. Delayed CINV
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share Forecast, 2019-2029
9. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
9.4.1. Acute CINV
9.4.2. Delayed CINV
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
9.7.1. Aloxi
9.7.2. Zofran Generic
9.7.3. Kytril Generic
9.7.4. Emend
9.7.5. Akynzeo
9.7.6. SUSTOL
9.7.7. Rolapitant
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share Forecast, 2019-2029
10. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
10.4.1. Acute CINV
10.4.2. Delayed CINV
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
10.7.1. Aloxi
10.7.2. Zofran Generic
10.7.3. Kytril Generic
10.7.4. Emend
10.7.5. Akynzeo
10.7.6. SUSTOL
10.7.7. Rolapitant
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share Forecast, 2019-2029
11. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
11.4.1. Acute CINV
11.4.2. Delayed CINV
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Chemotherpy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
11.7.1. Aloxi
11.7.2. Zofran Generic
11.7.3. Kytril Generic
11.7.4. Emend
11.7.5. Akynzeo
11.7.6. SUSTOL
11.7.7. Rolapitant
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share, 2019-2029
12. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
12.4.1. Acute CINV
12.4.2. Delayed CINV
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
12.7.1. Aloxi
12.7.2. Zofran Generic
12.7.3. Kytril Generic
12.7.4. Emend
12.7.5. Akynzeo
12.7.6. SUSTOL
12.7.7. Rolapitant
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share, 2019-2029
13. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Application
13.4.1. Acute CINV
13.4.2. Delayed CINV
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Volume Forecast by Type
13.7.1. Aloxi
13.7.2. Zofran Generic
13.7.3. Kytril Generic
13.7.4. Emend
13.7.5. Akynzeo
13.7.6. SUSTOL
13.7.7. Rolapitant
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Market Share Analysis
14.2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors and Customers
14.3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GlaxoSmithKline
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Helsinn
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Heron Therapeutics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Tesaro
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
&nbs
